Rakovina Therapeutics Inc. (TSXV:RKV)

Rakovina Therapeutics Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	0.82	1.31	0.44	0.9	2.81	0
Cash & Short-Term Investments	0.82	1.31	0.44	0.9	2.81	0
Cash Growth	222.41%	200.87%	-51.35%	-68.10%	40164771.43%	-
Other Receivables	0.15	0.08	0.02	0.01	0.07	0
Receivables	0.15	0.08	0.02	0.01	0.07	0
Prepaid Expenses	0.39	0.4	0.18	0.16	0.19	-
Other Current Assets	0.32	0.47	-	-	-	-
Total Current Assets	1.69	2.26	0.63	1.07	3.07	0
Other Intangible Assets	3.58	3.98	4.52	5.05	5.59	-
Total Assets	5.27	6.24	5.15	6.12	8.66	0
Accounts Payable	0.68	0.33	0.01	0.03	0.04	-
Accrued Expenses	0.06	0.2	0.15	0.08	0.07	0
Current Portion of Long-Term Debt	1.44	1.42	-	-	-	-
Total Current Liabilities	2.18	1.94	0.15	0.11	0.11	0
Long-Term Debt	1.16	-	1.33	-	-	-
Other Long-Term Liabilities	0.04	-	-	-	-	-
Total Liabilities	3.38	1.94	1.49	0.11	0.11	0
Common Stock	18.45	16.45	13.6	13.58	13.57	0
Additional Paid-In Capital	5.22	2.85	0.91	0.75	0.49	-
Retained Earnings	-21.79	-15	-10.93	-8.31	-5.52	-0
Comprehensive Income & Other	0	0	0.08	-	-	-
Shareholders' Equity	1.89	4.3	3.66	6.01	8.54	-0
Total Liabilities & Equity	5.27	6.24	5.15	6.12	8.66	0
Total Debt	2.6	1.42	1.33	-	-	-
Net Cash (Debt)	-1.77	-0.11	-0.9	0.9	2.81	0
Net Cash Growth	-	-	-	-68.10%	40164771.43%	-
Net Cash Per Share	-0.12	-0.01	-0.13	0.13	0.52	-
Filing Date Shares Outstanding	21.15	14	7.01	6.98	6.98	-
Total Common Shares Outstanding	21.15	14.05	7.01	6.98	6.98	-
Working Capital	-0.49	0.32	0.48	0.96	2.96	-0
Book Value Per Share	0.09	0.31	0.52	0.86	1.22	-
Tangible Book Value	-1.69	0.32	-0.86	0.96	2.96	-0
Tangible Book Value Per Share	-0.08	0.02	-0.12	0.14	0.42	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.